July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
ecancer – Ruben Mesa on Ropeginterferon’s Superiority in SURPASS-ET Trial
Jun 12, 2025, 10:33

ecancer – Ruben Mesa on Ropeginterferon’s Superiority in SURPASS-ET Trial

ecancer posted on X:

“The Phase 3 SURPASS-ET trial evaluates ropeginterferon alfa-2b versus anagrelide in patients with essential thrombocythaemia. Ropeginterferon shows superior safety and efficacy compared to anagrelide.
Watch full interview with Dr Ruben Mesa.”

More posts featuring Ruben Mesa.